Vaecgene Biotech GmbH

Company

    • Company type:
      • Manufacturer
    • Year founded:
    • 2000
    • Employees (at the site):
    • 2
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Vaecgene biotech is a specialized service provider for the pharmaceutical industry but also for researchers. We provide the tools necessary to generate new drugs and therapeutics. We will deliver new targets for the generation of therapeutic and diagnostic antibodies dedicated to the treatment of tumours, chronical infections and autoimmune diseases.
      Clinical Diagnostics, Proteomics, Drug Development

    • Core competencies:
    • Vaecgene focuses on the research and development of novel therapeutics and in vitro diagnostics. Core competence and proprietary technology are the development of viral vectors that helped Vaecgene to establish a broad portfolio including individual drugs for immunological treatment of tumors and infectious diseases. Recently, Vaecgene has developed a new intelligent technology, AMIDA, for functional proteomics for fast and efficient identification and validation of tumor markers for early detection of cancer. In addition, the company offers services related to Epstein-Barr Virus. The company has extensive experience in monitoring and quantitating the immune competence in patients. Vaecgene has the experience and ongoing cooperations to move drugs rapidly into the clinic and will initiate alliances for new product.

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Therapeutic drug development
    • Industries NACE:
      • 21.20: Manufacture of pharmaceutical preparations
      • 32.50: Manufacture of medical and dental instruments and supplies
      • 21.2: Manufacture of pharmaceutical preparations
      • 72.11: Research and experimental development on biotechnology
      • 72.19: Other research and experimental development on natural sciences and engineering
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Reinhard Zeidler (Mr.)
      - Management